TJ Biopharma

Hangzhou, China · Founded 2016 · Privately Held (backing)

Developer of biotechnology therapies specializing in autoimmune diseases, immuno-oncology, and metabolic disorders. TJ Biopharma is based in Hangzhou, China and was founded in 2016. Its last reported valuation was $459 million in Sep 2025. It has raised $84.2 million.

Last reported valuation

$459.2M

Oct 2026

Priced at

—

Total raised

$84.2M

Last round

—

How much has TJ Biopharma raised?

$84.2Macross 0 recorded rounds

Free account

More of TJ Biopharma with a free account

·The complete investor list: 13 names
·Watch TJ Biopharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

TJ Biopharma investors

13 investors are on record for TJ Biopharma, including HSG (Hong Kong), CICC Capital, Oriental Fortune Capital and Tailong VC.

For fundraisers

Raising for a company like TJ Biopharma?

13 investors have backed TJ Biopharma.

See all 13 investors →

Frequently asked about TJ Biopharma

How much has TJ Biopharma raised?: TJ Biopharma has raised $84.2M in total across 0 recorded funding rounds.